Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Suzuki O, Katsumata Y, Oya M, Bladt S, Wagner H (1984) Inhibition of monoamine oxidase by hypericin. Planta Med 50: 272–274
Bladt S, Wagner H (1994) Inhibition of MAO by fractions and constituents of Hypericum extract. J Geriatr Psychiatry Neurol 7(1): S57–59
Thiede HM, Walper A (1994) Inhibition of MAO and COMT by Hypericum extracts and hypericin. J Geriatr Psychiatry Neurol 7(1): S54–S56
Reuter HD (1993) Hypericum als pflanzliches Antidepressivum. Zeitschrift für Phytotherapie 14: 239–254
Demisch L, Hölzl J, Gollnik B, Kaczmarczyk P (1989) Identification of selective MAO-Type A inhibitors in Hypericum perforatum L. (Hyperforat). Pharmacopsychiatry 22: 194
Cott JM (1997) In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry 30: 108–112
Müller WE, Rolli M, Schäfer C, Hafner U (1997) Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 30: 102–107
Neary JT, Whittemore SR, Bu Y, Mehta H, Shi YF (2001) Biochemical mechanisms of action of Hypericum LI160 in glial and neuronal cells: inhibition of neurotransmitter uptake and stimulation of extracellular signal regulated protein kinase. Pharmacopsychiatry 34: S103–107
Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Müller WE (1998) Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci 63: 499–510
Gobbi M, Valle FD, Ciapparelli C, Diomede L, Morazzoni P, Verotta L, Caccia S, Cervo L, Mennini T (1999) Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol 360: 262–269
Jensen AG, Hansen SH, Nielsen EO (2001) Adhyperforin as a contributor to the effects of Hypericum perforatum L. in biochemical models of antidepressant activity. Life Sci 68: 1593–1605
Serdarevic N, Eckert GP, Müller WE (2001) The effects of extracts from St. John’s Wort and Kava Kava on brain neurotransmitter levels in the mouse. Pharmacopsychiatry 34: 134–136
Rommelspacher H, Siemanowitz B, Mannel M (2001) Acute and chronic actions of a dry methanolic extract of Hypericum perforatum and a hyperforin-rich extract on dopaminergic and serotoninergic neurones in rat nucleus accumbens. Pharmacopsychiatry 34: 119–126
Phillipu A (2001) In vivo neurotransmitter release in the loceus coereleus — effects of hyperforin, inescapable shock and fear. Pharmacopsychiatry 34: S111–115
Calapai G, Crupi A, Firenzuali F, Inferrera G, Squadrito F, Parisi A (2001) Serotonin, norepinephrine and dopamine involvement in the antidepressant action of Hypericum perforatum. Pharmacopsychiatry 34: 45–49
Teufel-Mayer R, Gleitz J (1997) Effects of long-term administration of Hypericum extracts on the affinity and density of central serotonergic 5HT-1 A and 5HT-2 A receptors. Pharmacopsychiatry 30(2): 113–116
Chen F, Rezvani AH, Lawrence AJ (2003) Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St. John’s Wort treatment. Naunyn-Schmiedeberg’s Arch Pharmacol 367: 126–133
Brockmoller J, Reum T, Bauer S, Kerb R, Hubner WD, Roots I (1997) Hypericin and pseudohy-pericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30(Suppl 2): 94–101
Müller WE, Schäfer C (1996) Johanniskraut. In vitro-Studie über Hypericum Extrakt, Hypericin und Kämperol als Antidepressiva. Dtsch Apoth Ztg 136: 1015–1022
Rolli M, Schäfer C, Müller WE (1995) Effect of Hypericum extract on neurotransmitter receptor binding and synaptosomal uptake systems. Pharmacopsychiatry 28: 207
Misane I, Ogren SO (2001) Effects of Hypericum perforatum (St. John’s Wort) on passive avoidance in the rat: evaluation of potential neurochemical mechanisms underlying its antidepressant activity. Pharmacopsychiatry 34(Suppl 1): S89–97
Singer A, Wonnemann M, Müller WE (1999) Hyperforin, a major antidepressant constituent of St. John’s Wort, inhibits serotonin uptake by elevating free intracellular Na+. J Pharmacol Exp Ther 290: 1363–1368
Wonnemann M, Singer A, Siebert B, Muller WE (2001) Evaluation of synaptosomal uptake inhibition of the most relevant constituents of St. John’s Wort. Pharmacopsychiatry 34: S148–152
Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14: 43–49
Kanner BI, Danbolt N, Pines G, Koepsell H, Seeberg E, Mathisen JS (1993) Structure and function of the sodium and potassium-coupled glutamate transporter from rat brain. Biochem Soc Trans 21: 59–61
Treiber K, Singer A, Henke B, Müller WE (2004) Hyperforin is a specific activator of non-selective cation channels. Brit J Pharmacol; in press
Buchholzer ML, Dovrak C, Chatterjee S, Klein J (2002) Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John’s Wort. JPET 301: 1–6
Wonnemann M, Singer A, Müller WE (2000) Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John’s Wort. The role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology 23: 188–197
Stamouli V, Vakirtzi-Lemonias C, Siffert W (1993) Thrombin and NaF, but not epinephrine, raise cytosolic free Na+ in human platelets. Biochim Biophys Acta 1176: 215–221
Reichardt LF, Kelly RB (1983) A molecular description of nerve terminal function. Annu Rev Biochem 52: 871–926
Tesfai Y, Brereton HM, Barritt GJ (2001) A diacylglycerol-activated Ca2+ channel in PC12 cells (an adrenal chromaffin cell line) correlates with the expression on TRP-6 (transient receptor potential) protein. Biochem J 358: 717–726
Merritt JE, Armstrong WP, Benham CD (1990) SKandF 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 271: 515–552
Goegelein H, Dahlem D, Englert HC, Lang HJ (1990) Flufenamic acid, mefenamic acid and niflumic acid inhibit single non-selective cation channels in the rat exocrine pancreas. FEBS Lett 268: 79–82
Kawanabe Y, Hashimoto N, Masaki T (2002) Characterisation of G proteins involved in activation of nonselective cation channels by endothelin (B) receptor. Br J Pharmacol 136: 1015–1022
Krautwurst D, Seifert R, Hescheler J, Schultz G (1992) Formyl peptides and ATP stimulate Ca2+ and Na+ inward currents through non-selective cation channels via G-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells. Involvement of Ca2+ and Na+ in the activation of beta-glucuronidase release and superoxide production. Biochem J 288 (Pt 3): 1025–1035
Miwa S, Iwamuro Y, Zhang XF, Kawanabe Y, Masaki T (2000) LOE 908: a specific blocker of non-selective cation channel. Cardiovasc Drug Rev 18: 61–72
Jung S, Mühle A, Schaefer M, Strotmann R, Schultz G, Plant TD (2003) Lanthanides potentiate TRPC5 currents by an action at extracellular sites close to the pore mouth. J Biol Chem 278(6): 3562–3571
Clapham DE (2003) TRP channels as cellular sensors. Nature 426: 517–524
Inoue R, Okada T, Onoue Y, Hara Y, Shimizu S, Naitoh S, Ito Y, Mori Y (2001) The transient receptor potential protein homologue TRP6 is the essential component of vascular α1-adrenoceptor-activated Ca2+-permeable cation channel. Circ Res 88: 325–332
Suzuki M, Murata M, Ikeda M, Miyoshi T, Imai M (1998) Primary structure and functional expression of a novel non-selective cation channel. Biochem Biophys Res Commun 242: 191–196
Liu RJ, van den Pol AN, Aghajanian GK (2002) Hypocretins (Orexin) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 22: 9453–9464
Clapham DE (2003) TRP channels as cellular sensors. Nature 426: 517–524
Eckert GP, Müller WE (2001) Effects of hyperforin on the fluidity of brain membranes. Pharmacopsychiatry 34(Suppl 1): S22–25
Wood EG, Eckert GP, Igbavboa U, Müller WE (2003) Amyloid beta-protein interactions with membranes and cholesterol: causes or causality for Alzheimer’s disease. Biochim Biophys Acta 1610: 281–290
Ropero S, Chiloeches A, Montes A, Toro-Nozal MJ (2003) Cholesterol cell content modulates GTPase activity of G-proteins in GH4C1 cell membranes. Cell Signall 15: 131–138
Keller JH, Karas M, Müller WE, Volmer DA, Eckert GP, Tawab MA, Blume HH, Dingermann T, Schubert-Zsilavecz M (2003) Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry. Anal Chem 75: 6084–6088
Eckert GP, Keller JH, Jourdan C, Karras M, Volmer DA, Schubert-Zsilavecz M, Müller WE (2004) Hyperforin modifies neuronal membrane properties in vivo. Neurosci Lett 367: 139–143
Roz N, Rehavi M (2003) Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membrane. Life Sci 73: 461–470
Froestl B, Steiner B, Müller WE (2003) Enhancement of proteolytic processing of the β-amyloid precursor protein by hyperforin. Biochem Pharmacol 66: 2177–2184
Klusa V, Germane S, Noldner M, Chatterjee SS (2001) Hypericum extract and hyperforin: memory-enhancing properties in rodents. Pharmacopsychiatry 34: S61–69
Holoubek G, Nöldner M, Müller WE (2001) Possible relationship between behavioral and biochemical changes following antidepressant activity. Soc Neurosci, Abstr. 572.14
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Birkhäuser Verlag/Switzerland
About this chapter
Cite this chapter
Treiber, K., Müller, W.E. (2005). Effects on transmitter uptake and their cellular and molecular basis. In: Müller, W.E. (eds) St. John’s Wort and its Active Principles in Depression and Anxiety. Milestones in Drug Therapy MDT. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7338-5_4
Download citation
DOI: https://doi.org/10.1007/3-7643-7338-5_4
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-6160-0
Online ISBN: 978-3-7643-7338-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)